155 related articles for article (PubMed ID: 2240157)
1. Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells.
Claudio L; Kress Y; Factor J; Brosnan CF
Am J Pathol; 1990 Nov; 137(5):1033-45. PubMed ID: 2240157
[TBL] [Abstract][Full Text] [Related]
2. Increased vesicular transport and decreased mitochondrial content in blood-brain barrier endothelial cells during experimental autoimmune encephalomyelitis.
Claudio L; Kress Y; Norton WT; Brosnan CF
Am J Pathol; 1989 Dec; 135(6):1157-68. PubMed ID: 2596575
[TBL] [Abstract][Full Text] [Related]
3. Effects of prazosin on the blood-brain barrier during experimental autoimmune encephalomyelitis.
Claudio L; Brosnan CF
Brain Res; 1992 Oct; 594(2):233-43. PubMed ID: 1450949
[TBL] [Abstract][Full Text] [Related]
4. Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
Paul D; Cowan AE; Ge S; Pachter JS
Microvasc Res; 2013 Mar; 86():1-10. PubMed ID: 23261753
[TBL] [Abstract][Full Text] [Related]
5. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
6. Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.
Sasaki M; Lankford KL; Brown RJ; Ruddle NH; Kocsis JD
Glia; 2010 Oct; 58(13):1523-31. PubMed ID: 20645414
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
Li XB; Schluesener HJ
Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
[TBL] [Abstract][Full Text] [Related]
8. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases.
Aubé B; Lévesque SA; Paré A; Chamma É; Kébir H; Gorina R; Lécuyer MA; Alvarez JI; De Koninck Y; Engelhardt B; Prat A; Côté D; Lacroix S
J Immunol; 2014 Sep; 193(5):2438-54. PubMed ID: 25049355
[TBL] [Abstract][Full Text] [Related]
9. Sequence of tissue responses in the early stages of experimental allergic encephalomyelitis (EAE): immunohistochemical, light microscopic, and ultrastructural observations in the spinal cord.
D'Amelio FE; Smith ME; Eng LF
Glia; 1990; 3(4):229-40. PubMed ID: 2144503
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis in the maturing central nervous system. Transfer of myelin basic protein-specific T line lymphocytes to neonatal Lewis rats.
Umehara F; Qin YF; Goto M; Wekerle H; Meyermann R
Lab Invest; 1990 Feb; 62(2):147-55. PubMed ID: 1689408
[TBL] [Abstract][Full Text] [Related]
11. Homing to central nervous system vasculature by antigen-specific lymphocytes. II. Lymphocyte/endothelial cell adhesion during the initial stages of autoimmune demyelination.
Raine CS; Cannella B; Duijvestijn AM; Cross AH
Lab Invest; 1990 Oct; 63(4):476-89. PubMed ID: 1700193
[TBL] [Abstract][Full Text] [Related]
12. Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis.
Stanislaus R; Singh AK; Singh I
J Neurosci Res; 2001 Oct; 66(2):155-62. PubMed ID: 11592110
[TBL] [Abstract][Full Text] [Related]
13. Analysis of V beta 8.2 CDR3 sequences from spinal cord T cells of Lewis rats vaccinated or treated with TCR V beta 8.2-39-59 peptide.
Buenafe AC; Vainiene M; Celnik B; Vandenbark AA; Offner H
J Immunol; 1995 Aug; 155(3):1556-64. PubMed ID: 7636217
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology.
Matsumoto Y; Hara N; Tanaka R; Fujiwara M
J Immunol; 1986 May; 136(10):3668-76. PubMed ID: 3084638
[TBL] [Abstract][Full Text] [Related]
15. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
Skundric DS; Huston K; Shaw M; Tse HY; Raine CS
Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
[TBL] [Abstract][Full Text] [Related]
16. Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis.
Jiang H; Zhang F; Yang J; Han S
Exp Neurol; 2014 Nov; 261():245-57. PubMed ID: 24852101
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic elimination of V beta 8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of V beta 8.2+ encephalitogenic T cells.
Tabi Z; McCombe PA; Pender MP
Eur J Immunol; 1994 Nov; 24(11):2609-17. PubMed ID: 7957554
[TBL] [Abstract][Full Text] [Related]
18. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
Berger T; Weerth S; Kojima K; Linington C; Wekerle H; Lassmann H
Lab Invest; 1997 Mar; 76(3):355-64. PubMed ID: 9121118
[TBL] [Abstract][Full Text] [Related]
19. Anergy induction in encephalitogenic T cells by brain microvessel endothelial cells is inhibited by interleukin-1.
Bourdoulous S; Béraud E; Le Page C; Zamora A; Ferry A; Bernard D; Strosberg AD; Couraud PO
Eur J Immunol; 1995 May; 25(5):1176-83. PubMed ID: 7539749
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.
McCombe PA; Nickson I; Tabi Z; Pender MP
J Neurol Sci; 1996 Jul; 139(1):1-6. PubMed ID: 8836965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
